Methodological aspects of desflurane application in modern anesthesiology. Review
#2020-4
PDF_2020-04_74-87 (Русский)
HTML_2020-04_74-87 (Русский)

Keywords

Desflurane
Pharmacology
Anesthetics
Methodology
inhalation
Anesthesia technique
Anesthesia recovery period
Adverse effects

How to Cite

Ovezov AM, Pivovarova AA, Halimov MR Methodological aspects of desflurane application in modern anesthesiology. Review. Annals of Critical Care. 2020;(4):74–87. doi:10.21320/1818-474X-2020-4-74-87.

Statistic

Abstract Views: 19
PDF_2020-04_74-87 (Русский) Downloads: 6
HTML_2020-04_74-87 (Русский) Downloads: 0
Plum Analytics

Language

English Русский

Social Networks

Keywords

Up

Abstract

Introduction. Desflurane is the last inhalational anesthetic approved for use in the Russian Federation. The experience of its use in the country in comparison with sevoflurane is still not great for a number of reasons, including the insufficient volume of methodological literature in Russian.

Objectives. To highlight the methodological aspects of the use of desflurane in modern anesthesiology.

Materials and methods. The search for sources was carried out using the resources of the Russian scientific electronic library (eLIBRARY.ru), the bibliographic database of articles from the US National Library of Medicine (NCBI), the ClinicalKey electronic library, and the Scopus abstract and citation database. The search depth is 7 years.

Results. A review of publications in 2014–2020, devoted to the methodology of using modern vapor-generating anesthetics, has been performed. The methodological techniques of anesthesia with desflurane are described in detail: inhalation induction, maintenance of anesthesia using a low and minimal flow of fresh gas, the peculiarities of the period of awakening and post-anesthetic rehabilitation are given.

Conclusion. Desflurane is not the drug of choice for inhalation induction of anesthesia, but has a number of distinctive feature: advantages for using with low or minimal fresh gas flow; superiority in speed and predictability of the period of early post-anesthetic rehabilitation; safety of use, both in elderly patients and in children; relevance for Outpatient anesthesiology, Bariatric surgery, and programs for Enhanced Recovery After Surgery.

https://doi.org/10.21320/1818-474X-2020-4-74-87
PDF_2020-04_74-87 (Русский)
HTML_2020-04_74-87 (Русский)

References

  1. Terrell R.C., Warner D.S. The Invention and Development of Enflurane, Isoflurane, Sevoflurane, and Desflurane. Anesthesiology. 2008; 108: 531–533. DOI: 10.1097/ALN.0b013e31816499cc
  2. Russell J.P., Szur A.J., Terrell R.C., inventors; Airco, Inc., assignee. Process for making fluorinated ethers. US patent 3897502. July 29, 1975. Available from: https://patentimages.storage.googleapis.com/1c/31/5f/81f5e3feec100a/US3897502.pdf
  3. Eger E.I. 2nd, Johnson B.H. MAC of 1-653 in rats, including a test of the effect of body temperature and anesthetic duration. Anesth Analg. 1987; 66: 974–976.
  4. Yasuda N., Targ A.G., Eger E.I. 2nd. Solubility of I-653, sevoflurane, isoflurane, and halotane in human tissues. Anesthesiology. 1988; 69(3a): A615.
  5. Eger E.I. 2nd, Johnson B.H. Rates of awakening from anesthesia with I-653, halothane, isoflurane, and sevoflurane: A test of the effect of anesthetic concentration and duration in rats. Anesthesia Analgesia. 1987; 66(10): 977–982.
  6. Jones R.M., Cashman J.N., Eger E.I. 2nd, et al. Kinetics and Potency of deflurane (1-653) in volunteers. Anesth Analg. 1990; 70: 3–7.
  7. Taylor R.H., Lerman J. Minimum alveolar concentration of desflurane and hemodynamic responses in neonates, infants, and children. Anesthesiology. 1991; 75(6): 975–979.
  8. Wrigley S.R., Jones R.M. New inhaled anaesthetics. Curr Opin Anaesthesiol. 1991; 4: 534–538.
  9. Warltier D.C., Pagel P.S. Cardiovascular and respiratory actions of desflurane: is desflurane different from isoflurane? Anesth Analg. 1992; 75(Suppl. 2): 17–31.
  10. Conzen P., Peter K. Pharmacodynamics of inhaled anaesthetics. Curr Opin Anaesthesiol. 1992; 5: 515–525.
  11. Ikeda K., Katoh T. Pharmacokinetics and Pharmacodynamics of new volatile anesthetics. Curr Opin Anaesthesiol. 1993; 6: 639–643.
  12. Eger E.I. The clinical use of desflurane. Yale J Biol Med. 1993; 66(5): 491–500.
  13. Weiskopf R.B., Eger E.I., Noorani M., et al. Repetitive rapid increases in desflurane concentration blunt transient cardiovascular stimulation in humans. Anesthesiology. 1994; 81(4): 843–9.
  14. Eger E.I. 2nd. New inhaled anesthetics. Anesthesiology. 1994; 80(4): 906–22.
  15. Patel S.S., Goa K.L. Desflurane. A Review of its Pharmacodynamic and Pharmacokinetic Properties and its Efficacy in General Anaesthesia. Drugs. 1995; 50(4): 742–767.
  16. Евдокимов Е.А., Лихванцев В.В., Замятин М.Н., Лекманов А.У. Современная ингаляционная анестезия. Медицинский алфавит. 2013; 1(8): 5–14. [Evdokimov E.A., Likhvantsev V.V., Zamiatin M.N., Lekmanov A.U. Sovremennaya ingalyacionnaya anesteziya. Medicinskij alfavit. 2013; 1(8): 5–14. (In Russ)]
  17. Лекманов А.У. Десфлуран у детей. Медицинский алфавит. 2013; 1(8): 16–20. [Lekmanov A.U. Desfluran u detej. Medicinskij alfavit. 2013; 1(8): 16–20. (In Russ)]
  18. Анисимов М.А., Горобец Е.С. Анестезиологическое обеспечение лапароскопической пангистерэктомии у пациентки с массой тела 200 кг (клиническое наблюдение). Регионарная анестезия и лечение острой боли. 2014; 8(3): 51–56. [Anisimov M.A., Gorobets E.S. Anesteziologicheskoe obespechenie laparoskopicheskoj pangisterektomii u pacientki s massoj tela 200 kg (klinicheskoe nablyudenie). Regionarnaya anesteziya i lechenie ostroj boli. 2014; 8(3): 51–56. (In Russ)]
  19. Чуприн С.В., Гиринская Л.Н., Сушкова О.В. и др. Оценка эффективности применения десфлурана и севофлурана при анестезиологическом обеспечении гинекологических операций. Вестник интенсивной терапии. 2014; 2: 51–56. [Chuprin S.V., Girinskaia L.N., Sushkova O.V., et al. Ocenka effektivnosti primeneniya desflurana i sevoflurana pri anesteziologicheskom obespechenii ginekologicheskih operacij. Vestn. intensivnoj terapii. 2014; 2: 51–56. (In Russ)]
  20. Лихванцев В.В., Мироненко А.В., Габитов М.В. и др. Клиническая значимость различий в скорости посленаркозного восстановления после операций, выполненных в условиях современных вариантов общей анестезии. Вестн. анестезиологии и реаниматологии. 2014; 11(3): 3–9. [Likhvantsev V.V., Mironenko A.V., Gabitov M.V., et al. Klinicheskaya znachimost’ razlichij v skorosti poslenarkoznogo vosstanovleniya posle operacij, vypolnennyh v usloviyah sovremennyh variantov obshchej anestezii. Vestn. anesteziologii i reanimatologii. 2014; 11(3): 3–9. (In Russ)]
  21. Лихванцев В.В., Мироненко А.В., Габитов М.В. и др. Ускоренное ведение послеоперационного периода у пациента с морбидным ожирением после десятичасовой анестезии. Анестезиология и реаниматология. 2014; 3: 77–79. [Likhvantsev V.V., Mironenko A.V., Gabitov M.V., et al. Uskorennoe vedenie posleoperacionnogo perioda u pacienta s morbidnym ozhireniem posle desyatichasovoj anestezii. Anesteziologiya i reanimatologiya. 2014; 3: 77–79. (In Russ)]
  22. Мощев Д.А., Лубнин А.Ю. Применение десфлурана в анестезиологии. Анестезиология и реаниматология. 2014; 1: 71–78. [Moshchev D.A., Lubnin A.Yu. Primenenie desflurana v anesteziologii. Anesteziologiya i reanimatologiya. 2014; 1: 71–78. (In Russ)]
  23. Лихванцев В.В., Мироненко А.В., Габитов М.В., Скрипкин Ю.В. Общая анестезия на основе десфлурана в некардиальной хирургии: учеб. пособие. М., 2014: 32. ISBN 978-5-98511-259-7. [Likhvantsev V.V., Mironenko A.V., Gabitov M.V., Skripkin Iu.V. Obshchaya anesteziya na osnove desflurana v nekardial’noj hirurgii: ucheb. posobie. M., 2014: 32. (In Russ)]
  24. Скобелев Е.И., Пасечник И.Н., Рыбинцев В.Ю. Ингаляционная анестезия как компонент программы ускоренного восcтановления после хирургических операций. Доктор.Ру. Анестезиология и реаниматология. Медицинская реабилитация. 2015; 15(116)–16(117): 32–36. [Skobelev E.I., Pasechnik I.N., Rybintsev V.Yu. Ingalyacionnaya anesteziya kak komponent programmy uskorennogo vosctanovleniya posle hirurgicheskih operacij. Doktor.Ru. Anesteziologiya i reanimatologiya. Medicinskaya reabilitaciya. 2015; 15(116)–16(117): 32–36. (In Russ)]
  25. Чепурняк Е.Ю., Панов А.В., Локшин Л.С. Применение ингаляционных анестетиков во время искусственного кровообращения. Вестн. анестезиологии и реаниматологии. 2018; 15(4): 70–75. DOI: 10.21292/2078-5658-2018-15-4-70-75 [Chepurnyak E.Yu., Panov А.V, Lokshin L.S. Primenenie ingalyacionnyh anestetikov vo vremya iskusstvennogo krovoobrashcheniya. Vestn. anesteziologii i reanimatologii. 2018; 15(4): 70–75. (In Russ)]
  26. Longnecker D.E., Newman M.F., Zapol W.M., et al. Anesthesiology. 3th ed. McGraw Hill Professional; 2018: 1694. ISBN 9780071848817
  27. McKay R.E. Inhaled Anesthetics. In: Basics of Anesthesia. 7th ed. 2018: 83–103. DOI: 10.1016/B978-0-323-40115-9.00007-4
  28. Nickalls R.W., Mapleson W.W. Age-related iso-MAC charts for isoflurane, sevoflurane and desflurane in man. Br J Anaesth. 2003; 91(2): 170–4. DOI: 10.1093/bja/aeg132
  29. Aranake A., Mashour G.A., Avidan M.S. Minimum alveolar concentration: ongoing relevance and clinical utility. Anaesthesia. 2013; 68(5): 512–22. DOI: 10.1111/ anae.12168
  30. Lobo S.A., Ojeda J., Lopez J. Minimum Alveolar Concentration. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2020. Available from: https://www.ncbi.nlm.nih.gov/books/NBK532974/ (accessed 11.08.2020).
  31. Sato N., Terada T., Ochiai R. MAC value of desflurane may vary for different machines. J Anesth. 2016; 30: 183. DOI: 10.1007/s00540-015-2068-y
  32. Kim J.K., Kim D.K., Lee M.J. Relationship of bispectral index to minimum alveolar concentration during isoflurane, sevoflurane or desflurane anaesthesia. J Int Med Res. 2014; 42(1): 130–7. DOI: 10.1177/0300060513505525
  33. Ryu K., Song K., Kim J., et al. Comparison of the Analgesic Properties of Sevoflurane and Desflurane Using Surgical Pleth Index at Equi-Minimum Alveolar Concentration. Int J Med Sci. 2017; 14(10): 994–1001. DOI: 10.7150/ijms.20291
  34. Ryu K.H., Song K., Lim T.Y., et al. Does Equi-Minimum Alveolar Concentration Value Ensure Equivalent Analgesic or Hypnotic Potency?: A Comparison between Desflurane and Sevoflurane. Anesthesiology. 2018; 128(6): 1092–1098. DOI: 10.1097/ALN.0000000000002158
  35. Ryu K.H., Kim J.A., Ko D.C., et al. Desflurane reduces intraoperative remifentanil requirements more than sevoflurane: comparison using surgical pleth index-guided analgesia. Br J Anaesth. 2018; 121(5): 1115–1122. DOI: 10.1016/j.bja.2018.05.064
  36. Лихванцев В.В., Борисов К.Ю., Габитов М.В. и др. Ингаляционная индукция и поддержание анестезии. Под ред. В.В. Лихванцева. М.: МИА, 2013: 320. ISBN: 978-5-9986-0107-1 [Likhvantsev V.V., Borisov K.Iu., Gabitov M.V., et al. Ingalyacionnaya indukciya i podderzhanie anestezii. Pod red. V.V. Lihvanceva. M.: MIA, 2013: 320. (In Russ)]
  37. Sommerfield D., von Ungern-Sternberg B.S. The mask or the needle? Which induction should we go for? Curr Opin Anaesthesiol. 2019; 32(3): 377–383. DOI: 10.1097/ACO.0000000000000729
  38. Porter L.L., Blaauwendraad S.M., Pieters B.M. Respiratory and hemodynamic perioperative adverse events in intravenous versus inhalational induction in pediatric anesthesia: A systematic review and meta-analysis. PaediatrAnaesth. 2020; 30(8): 859–866. DOI: 10.1111/pan.13904
  39. Халимов М.Р., Овезов А.М., Гребенчиков О.А. и др. Индукция анестезии на основе десфлурана и фентанила. Опасности в амбулаторной хирургии. Анестезиология и реаниматология. 2015; 60(2): 44–47. [Khalimov M.R., Ovezov A.M., Grebenchikov O.A., et al. Indukciya anestezii na osnove desflurana i fentanila. Opasnosti v ambulatornoj hirurgii. Anesteziologiya i reanimatologiya. 2015; 60(2): 44–47. (In Russ)]
  40. Гребенчиков О.А., Мурачев А.С., Левиков Д.И. и др. Ингаляционная индукция на основе севофлурана у пожилых больных высокого риска в некардиальной хирургии. Общая реаниматология. 2011; 7(3): 59. DOI: 10.15360/1813-9779-2011-3-59. [Grebenchikov O.A., Murachev A.S., Levikov D.I., et al. Ingalyacionnaya indukciya na osnove sevoflurana u pozhilyh bol’nyh vysokogo riska v nekardial’noj hirurgii. Obshchaya reanimatologiya. 2011; 7(3): 59. (In Russ)]
  41. Rajan S., Mathew J., Tosh P., Sudevan M. Safety of inhalational anesthesia in patients with multiple drug allergies presenting for major surgeries under general anesthesia. Anesth Essays Res. 2019; 13: 259–63. DOI: 10.4103/aer.AER_28_19
  42. SUPRANE (desflurane, USP). Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020118s016lbl.pdf.
  43. Desflurane — Drug Summary. Available from: https://www.pdr.net/drug-summary/Suprane-desflurane-2257.
  44. Yoo J.Y., Lee S.Y., Jeong H.W., et al. Effect-site concentration of remifentanil for smooth inhalational induction with desflurane. J Int Med Res. 2016; Oct: 1013–1022. DOI: 10.1177/0300060516652761
  45. Staikou C., Stamelos M., Stavroulakis E. Impact of anaesthetic drugs and adjuvants on ECG markers of torsadogenicity. Br J Anaesth. 2014; 112(2): 217–230. DOI: 10.1093/bja/aet412
  46. Aroke E.N., Nkemazeh R.Z. Perianesthesia Implications and Considerations for Drug-Induced QT Interval Prolongation. J Perianesth Nurs. 2020; 35(2): 104–111. DOI: 10.1016/j.jopan.2019.09.003
  47. Kao M.C., Tzeng I.S., Chan H.L. Esmolol pretreatment attenuates heart rate increase and parasympathetic inhibition during rapid increases in desflurane concentration: A preliminary randomized study. Medicine (Baltimore). 2017; 96(42): e8340. DOI: 10.1097/MD.0000000000008340
  48. Tominaga S., Terao Y., Urabe S., et al. The effects of intravenous anesthetics on QT interval during anesthetic induction with desflurane. JA Clin Rep. 2018; 4(1): 57. DOI: 10.1186/s40981-018-0195-9
  49. Kumari K., Samra T., Saini V., et al. Comparison of Haemodynamic Response to Inhalational Bolus with Desflurane in Normotensive and Hypertensive Patients Undergoing Laparoscopic Cholecystectomy. Turk J Anaesthesiol Reanim. 2019; 47(3): 165–172. DOI: 10.5152/TJAR.2018.93457
  50. De Hert S.G., Turani F., Mathur S., Stowe D.F. Cardioprotection with volatile anesthetics: mechanisms and clinical implications. Anesth Analg. 2005; 100(6): 1584–93. DOI: 10.1213/01.ANE.0000153483.61170.0C
  51. Лихванцев В.В., Гребенчиков О.А., Черпаков Р.А. и др. Влияние прекондиционирования десфлураном на содержание фосфорилированной формы гликоген синтетазы-киназы 3β в эксперименте. Общая реаниматология. 2016; 12(6): 8–15. DOI: 10.15360/1813-9779-2016-6-8-15. [Lihvancev V.V., Grebenchikov O.A., Cherpakov R.A., et al. Vliyanie prekondicionirovaniya desfluranom na soderzhanie fosforilirovannoj formy glikogen sintetazy-kinazy 3β v eksperimente. Obshchaya reanimatologiya. 2016; 12(6): 8–15. DOI: 10.15360/1813-9779-2016-6-8-15. (In Russ)]
  52. Герасименко О.Н., Гребенчиков О.А., Овезов А.М. и др. Анестетическое прекондиционирование в кардиохирургии. Альманах клинической медицины. 2017; 45(3): 172–180. DOI: 10.18786/2072-0505-2017-45-3-172-180. [Gerasimenko O.N., Grebenchikov O.A., Ovezov A.M., et al. Anesteticheskoe prekondicionirovanie v kardiohirurgii. Al’manah klinicheskoj mediciny. 2017; 45(3): 172–180. (In Russ)]
  53. ULTANE® (sevoflurane), volatile liquid for inhalation. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020478s016lbl.pdf.
  54. Brattwall M., Warrén-Stomberg M., Hesselvik F., Jakobsson J. Brief review: theory and practice of minimal fresh gas flow anesthesia. Can J Anaesth. 2012; 59(8): 785–97. DOI: 10.1007/s12630-012-9736-2
  55. Bilgi M., Goksu S., Mizrak A., et al. Comparison of the effects of low-flow and high-flow inhalational anaesthesia with nitrous oxide and desflurane on mucociliary activity and pulmonary function tests. Eur J Anaesthesiol. 2011; 28(4): 279–83. DOI: 10.1097/EJA.0b013e3283414cb7
  56. Braz J.R.C., Braz M.G., Hayashi Y., et al. Effects of different fresh gas flows with or without a heat and moisture exchanger on inhaled gas humidity in adults undergoing general anaesthesia: A systematic review and meta-analysis of randomised controlled trials. Eur J Anaesthesiol. 2017; 34(8): 515–525. DOI: 10.1097/EJA.0000000000000633
  57. Cui Y., Wang Y., Cao R., et al. The low fresh gas flow anesthesia and hypothermia in neonates undergoing digestive surgeries: a retrospective before-after study. BMC Anesthesiol. 2020; 20(1): 223. DOI: 10.1186/s12871-020-01140-5
  58. Leelanukrom R., Tuchinda L., Jiamvorakul P., Koomwong A. Desflurane concentrations and consumptions during low flow anesthesia. J Med Assoc Thai. 2014; 97(1): 64–70.
  59. Золотарева Л.С., Папонов О.Н., Степаненко С.М., Исаков А.В. Сравнительная оценка экономической эффективности применения десфлурана и севофлурана в ЛОР хирургии. Российский вестник детской хирургии, анестезиологии и реаниматологии. 2019; 9(4): 69–77. Режим доступа: https://doi.org/10.30946/2219-4061-2019-9-4-69-77. DOI: 10.30946/2219-4061-2019-9-4-69-77 [Zolotareva L.S., Paponov O.N., Stepanenko S.M., Isakov A.V. Sravnitel’naya ocenka ekonomicheskoj effektivnosti primeneniya desflurana i sevoflurana v LOR hirurgii. Rossijskij vestnik detskoj hirurgii, anesteziologii i reanimatologii. 2019; 9(4): 69–77. Available from: https://doi.org/10.30946/2219-4061-2019-9-4-69-77. (In Russ)]
  60. Petre M.A., Malherbe S. Environmentally sustainable perioperative medicine: simple strategies for anesthetic practice. Can J Anaesth. 2020; 67(8): 1044-1063. DOI: 10.1007/s12630-020-01726-0
  61. Gordon D. Sustainability in the Operating Room. Reducing Our Impact on the Planet. Anesthesiology Clin. 2020; 38: 679–692. DOI: 10.1016/j.anclin.2020.06.006
  62. Van Norman G.A., Jackson S. The anesthesiologist and global climate change: an ethical obligation to act. Curr Opin Anaesthesiol. 2020; 33(4): 577–583. DOI: 10.1097/ACO.0000000000000887
  63. Sathitkarnmanee T., Tribuddharat S., Suttinarakorn C., et al. 1–1–12 one-step wash-in scheme for desflurane-nitrous oxide low-flow anesthesia: rapid and predicTable induction. Biomed Res Int. 2014; 2014: 867504. DOI: 10.1155/2014/867504
  64. Sathitkarnmanee T., Tribuddharat S., Nonlhaopol D., et al. 1–1–12 one-step wash-in scheme for desflurane low flow anesthesia: performance without nitrous oxide. Drug Des Devel Ther. 2015; 9: 977–981. DOI: 10.2147/DDDT.S78233
  65. Khetarpal R., Attri J.P., Banerjee A., Verma R. Advantages of 1–1–12 Wash in Scheme during Induction with Low Flow Anesthesia with and without Nitrous Oxide. Anesth Essays Res. 2018; 12(2): 371–376. DOI: 10.4103/aer.AER_20_18
  66. Horwitz M., Jakobsson J.G. Desflurane and sevoflurane use during low- and minimal-flow anesthesia at fixed vaporizer settings. Minerva Anestesiol. 2016; 82(2): 180–185.
  67. Bahar S., Arslan M., Urfalioglu A., et al. Low-flow anaesthesia with a fixed fresh gas flow rate. J Clin Monit Comput. 2019; 33(1): 115–121. DOI: 10.1007/s10877-018-0135-2
  68. Toal P., Chiplonkar S., Panchal P. A randomised prospective comparison of equilibration point and changing gas composition during low-flow anaesthesia with sevoflurane vs desflurane. Indian J Anaesth. 2019; 63(10): 814–819. DOI: 10.4103/ija.IJA_31_19
  69. Biricik E., Karacaer F., Güneş Y., et al. Effect of One-Lung Ventilation on Blood Sevoflurane and Desflurane Concentrations. J Cardiothorac Vasc Anesth. 2019; 33(2): 442–449. DOI: 10.1053/j.jvca.2018.05.032
  70. Gelzinis T.A. An Editorial to the Effect of One-Lung Ventilation on Blood Sevoflurane and Desflurane Concentration. J Cardiothorac Vasc Anesth. 2019; 33(2): 450–452. DOI: 10.1053/j.jvca.2018.07.021
  71. Upadya M., Saneesh P.J. Low-flow anaesthesia — underused mode towards “sustainable anaesthesia”. Indian J Anaesth. 2018; 62(3): 166–172. DOI: 10.4103/ija.IJA_413_17
  72. Халимов М.Р., Овезов А.М., Гребенчиков О.А. и др. Сравнительная характеристика периодов поддержания анестезии и посленаркозного пробуждения при анестезии на основе севофлурана и десфлурана в амбулаторной хирургии. Вестн. анестезиологии и реаниматологии. 2015; 12(1): 3–11. DOI: 10.21292/2078-5658-2015-12-1-3-11 [Khalimov M.R., Ovezov A.M., Grebenchikov O.A., et al. Sravnitel’naya harakteristika periodov podderzhaniya anestezii i poslenarkoznogo probuzhdeniya pri anestezii na osnove sevoflurana i desflurana v ambulatornoj hirurgii. Vestn. anesteziologii i reanimatologii. 2015; 12(1): 3–11. (In Russ)]
  73. Stevanovic A., Rossaint R., Fritz H.G., et al. Airway reactions and emergence times in general laryngeal mask airway anaesthesia: a meta-analysis. Eur J Anaesthesiol. 2015; 32(2): 106–16. DOI: 10.1097/EJA.0000000000000183
  74. Alonso M., Builes L., Morán P., et al. Clinical experience with desflurane for paediatric anaesthesia outside the operating room. Experiencia clínica con desflurano para anestesia pediátrica fuera de quirófano. Rev Esp Anestesiol Reanim. 2017; 64(1): 6–12. DOI: 10.1016/j.redar.2016.04.007
  75. Benhamou D., Constant I., Longrois D., et al. Use of volatile anaesthetic agents in anaesthesia: A survey of practice in France in 2012. Anaesth Crit Care Pain Med. 2015; 34(4): 205–9. DOI: 10.1016/j.accpm.2015.01.006
  76. McGain F., Bishop J.R., Elliot-Jones L.M., et al. A survey of the choice of general anaesthetic agents in Australia and New Zealand. Anaesth Intensive Care. 2019; 47(3): 235–241. DOI: 10.1177/0310057X19836104
  77. Козырев А.С., Александрович Ю.С., Залетина А.В. и др. Сравнительная оценка анестезии десфлураном и севофлураном при хирургической коррекции позвоночно-спинномозговой травмы у детей. Ортопедия, травматология и восстановительная хирургия детского возраста. 2018; 6(3): 47–55. DOI: 10.17816/PTORS6347-55. [Kozyrev A.S., Aleksandrovich Iu.S., Zaletina A.V., et al. Sravnitel’naya ocenka anestezii desfluranom i sevofluranom pri hirurgicheskoj korrekcii pozvonochno-spinnomozgovoj travmy u detej. Ortopediya, travmatologiya i vosstanovitel’naya hirurgiya detskogo vozrasta. 2018; 6(3): 47–55. (In Russ)]
  78. Yu H., Zhang L., Ma Y., Yu H. Early postoperative recovery in operating room after desflurane anesthesia combined with Bispectral index (BIS) monitoring and warming in lengthy abdominal surgery: a randomized controlled study. BMC Anesthesiol. 2018; 18(1): 110. DOI: 10.1186/s12871-018-0577-6
  79. Bai Y., Li C.S., Lu X.H., et al. Effects of desflurane and sevoflurane anesthesia on postoperative recovery after long-term tumor surgery. Zhonghua Yi Xue Za Zhi. 2020; 100(29): 2278–2282. Chinese. DOI: 10.3760/cma.j.cn112137-20200422-01273.
  80. Singh P.M., Borle A., McGavin J., et al. Comparison of the Recovery Profile between Desflurane and Sevoflurane in Patients Undergoing Bariatric Surgery-a Meta-Analysis of Randomized Controlled Trials. Obes Surg. 2017; 27(11): 3031–3039. DOI: 10.1007/s11695-017-2929-6
  81. Сырчин Е.Ю., Лахин Р.Е., Давлетшина Э.М., Гражданкин А.А. Периоперационное обезболивание пациентки с морбидным ожирением при бариатрической операции (клинический случай). Вестник интенсивной терапии им. А.И. Салтанова. 2020; 2: 146–153. DOI: 10.21320/1818-474X-2020-2-146-153. [Syrchin E.Yu., Lakhin R.E., Davletshina E.M., Grazhdankin A.A. Perioperacionnoe obezbolivanie pacientki s morbidnym ozhireniem pri bariatricheskoj operacii (klinicheskij sluchaj). Vestn. intensivnoj terapii im. A.I. Saltanova. 2020; 2: 146–153. (In Russ)]
  82. Trotta M., Ferrari C., D’Alessandro G., et al. Enhanced recovery after bariatric surgery (ERABS) in a high-volume bariatric center. Surg Obes Relat Dis. 2019; 15(10): 1785–1792. DOI: 10.1016/j.soard.2019.06.038
  83. Chen G., Zhou Y., Shi Q., Zhou H. Comparison of early recovery and cognitive function after desflurane and sevoflurane anaesthesia in elderly patients: A meta-analysis of randomized controlled trials. J Int Med Res. 2015; 43(5): 619–28. DOI: 10.1177/0300060515591064
  84. Li Y., Deng R., Zhou J., et al. The efficacy and safety of desflurane versus sevoflurane in elderly patients during general anaesthesia: A meta-analysis randomized controlled trials. Med ResInnov. 2018; 2(4): 1–5. DOI: 10.15761/MRI.1000148
  85. Tsukamoto M., Yamanaka H., Yokoyama T. Age-related differences in recovery from inhalational anesthesia: a retrospective study. Aging Clin Exp Res. 2018; 30(12): 1523–1527. DOI: 10.1007/s40520-018-0924-y
  86. Wang C., Li L., Xu H., et al. Effect of desflurane-remifentanil or sevoflurane-remifentanil on early recovery in elderly patients: a meta-analysis of randomized controlled trials. Pharmazie. 2019; 74(4): 201–205. DOI: 10.1691/ph.2019.8935
  87. Werner J.G., Castellon-Larios K., Thongrong C., et al. Desflurane allows for a faster emergence when compared to sevoflurane without affecting the baseline cognitive recovery time. Front. Med. 2015; 2: 75. DOI: 10.3389/fmed.2015.00075
  88. Агеенко А.М., Лебедева М.Н., Волков С.Г., Голиков Р.И. Cравнение скорости восстановления когнитивной функции после анестезии севофлюраном и десфлюраном при нейроортопедических вмешательствах. Современные проблемы науки и образования. 2016; 5. Режим доступа: http://www.science-education.ru/ru/article/view?id = 25338. [Ageenko A.M., Lebedeva M.N., Volkov S.G., Golikov R.I. Cravnenie skorosti vosstanovleniya kognitivnoj funkcii posle anestezii sevoflyuranom i desflyuranom pri nejroortopedicheskih vmeshatel’stvah. Sovremennye problemy nauki i obrazovaniya. 2016; 5. Available from: http://www.science-education.ru/ru/article/view?id = 25338. (In Russ)]
  89. Rocha R.G., Almeida E.G., Carneiro L.M.M, et al. Anesthesia recovery comparison between remifentanil-propofol and remifentanil-desflurane guided by Bispectral Index® monitoring. Rev Bras Anestesiol. 2017; 67(5): 500–507. DOI: 10.1016/j.bjan.2017.04.024.
  90. Неймарк М.И., Киселев Р.В. Сравнение вариантов анестезии и периоперационной анальгезии при симультанной гернио- и абдоминопластике вентральных грыж у пациентов с ожирением. Вестник интенсивной терапии имени А.И. Салтанова. 2019; 1: 45–51. DOI: 10.21320/1818-474X-2019-1-45-51. [Neimark M.I., Kiselev R.V. Sravnenie variantov anestezii i perioperacionnoj anal’gezii pri simul’tannoj gernio- i abdominoplastike ventral’nyh gryzh u pacientov s ozhireniem. Vestn. intensivnoj terapii imeni A.I. Saltanova. 2019; 1: 45–51. (In Russ)]
  91. Mikuni I., Harada S., Yakushiji R., Iwasaki H. Effects of changing from sevoflurane to desflurane on the recovery profile after sevoflurane induction: a randomized controlled study. Can J Anaesth. 2016; 63(3): 290–7. DOI: 10.1007/s12630-015-0514-9.
  92. Kowark A., Rossaint R., Pühringer F., et al. Emergence times and airway reactions during general anaesthesia with remifentanil and a laryngeal mask airway: A multicentrerandomised controlled trial. Eur J Anaesthesiol. 2018; 35(8): 588–597. DOI: 10.1097/EJA.0000000000000852
  93. Pin-On P., Leurcharusmee P., Tanasungnuchit S., et al. Desflurane is not inferior to sevoflurane in the occurrence of adverse respiratory events during laryngeal mask airway anesthesia: a non-inferiority randomized double-blinded controlled study. Minerva Anestesiol. 2020; 86(6): 608–616. DOI: 10.23736/S0375-9393.20.14202-0
  94. Huang P.J., Kang Y.N., Tsai P.S., et al. Noninferior of desflurane to sevoflurane in the occurrence of adverse respiratory events during laryngeal mask airway anesthesia in pediatrics: a systematic review and meta-analysis of randomized controlled studies. Minerva Anestesiol. 2020; Aug 5. DOI: 10.23736/S0375-9393.20.14955-1.
  95. Jeong J.S., Yoon S.W., Choi S.L., et al. Comparison of emergence times with different fresh gas flow rates following desflurane anaesthesia. J Int Med Res. 2014; 42(6): 1285–93. DOI: 10.1177/0300060514546939
  96. Pakpirom J., Kraithep J., Pattaravit N. Length of postanesthetic care unit stay in elderly patients after general anesthesia: a randomized controlled trial comparing desflurane and sevoflurane. J Clin Anesth. 2016; 32: 294–9. DOI: 10.1016/j.jclinane.2015.08.016.
  97. Jae Y., Hyun K., Chong Wha B., et al. Comparison of effects of desflurane and sevoflurane on postoperative nausea, vomiting, and pain in patients receiving opioid-based intravenous patient-controlled analgesia after thyroidectomy, Medicine. 2017; 96(16): e6681. DOI: 10.1097/MD.0000000000006681
  98. Boggett S., Ou-Young J., Heiberg J., et al. A randomized trial of desflurane or sevoflurane on postoperative quality of recovery after knee arthroscopy. PLoS One. 2019; 14(8): e0220733. DOI: 10.1371/journal.pone.0220733
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Downloads

Download data is not yet available.